31 Jan 2024


31 January 2024: Trilegal represented Goldman Sachs (India) Alternative Investment Management Private Limited (Goldman Sachs India) and its affiliates in securing an unconditional approval from the Competition Commission of India (CCI), in relation to the proposed subscription of shares in API Holdings Limited (API). The CCI approved the transaction on 30 January 2024.
Trilegal represented Goldman Sachs India on the Indian competition law aspects of the transaction and filed a merger notification with the CCI. Trilegal demonstrated that the proposed transaction would not cause any appreciable adverse effect on competition in India in any of the relevant markets.
Goldman Sachs India is an indirect subsidiary of The Goldman Sachs Group, Inc. which is a global investment banking, securities and investment management firm that provides a range of banking, securities and investment services worldwide to a substantial and diversified client base that includes corporations, financial institutions, governments and high net-worth individuals.
API is engaged in various activities in the pharmaceutical and healthcare sector in India and owns the ‘Pharmeasy’ platform.
Trilegal competition team was led by Nisha Kaur Uberoi, Partner & National Head – Competition Law and Gautam Chawla, Partner; and assisted by Senior Associates Afreen Abbassi and Ankush Walia; and Associates Mehar Dang, Varalika Mendiratta and Shaurya Kashyap.
Cyril Amarchand Mangaldas advised API on corporate law aspects of the transaction.
For more information, please contact:
Roomi Irani
Mob: +912240791000 | BD@trilegal.com

Deal: Trilegal advises Macquarie Corporate Holdings on the sale of Vibrant Energy to Inox Clean Energy

Deal: Trilegal advises Elliott Investment Management L.P. on CCI approval for its significant investment in Toyota Industries Corporation

The quiet death of ADRs: Why investors no longer need Wall Street’s window into India
Under the rules of the Bar Council of India, Trilegal is prohibited from soliciting work or advertising in any form or manner. By accessing this website, www.trilegal.com, you acknowledge that:
We prioritize your privacy. Before proceeding, we encourage you to read our privacy policy, which outlines the below, and terms of use to understand how we handle your data:
For more information, please read our terms of use and our privacy policy.